PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 146 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $313,000 | -65.9% | 42,500 | -68.6% | 0.00% | -69.2% |
| Q2 2017 | $918,000 | +128.4% | 135,400 | +113.1% | 0.01% | +116.7% |
| Q3 2016 | $402,000 | -58.0% | 63,548 | -59.3% | 0.01% | -14.3% |
| Q4 2015 | $958,000 | -5.2% | 156,268 | -11.5% | 0.01% | -53.3% |
| Q3 2015 | $1,011,000 | +156.6% | 176,629 | +234.5% | 0.02% | +200.0% |
| Q2 2015 | $394,000 | +12.3% | 52,800 | +13.6% | 0.01% | +25.0% |
| Q4 2014 | $351,000 | -50.4% | 46,478 | -73.1% | 0.00% | -55.6% |
| Q1 2014 | $708,000 | -47.1% | 172,960 | -35.2% | 0.01% | -35.7% |
| Q3 2013 | $1,339,000 | +287.0% | 266,719 | +244.4% | 0.01% | +366.7% |
| Q2 2013 | $346,000 | – | 77,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |